cerrar
Tagged with GE

Ameet Mallik – EVP, Head of US, Novartis Oncology
Ameet Mallik, Executive VP and Head of Oncology for the US at Novartis Oncology highlights the company's culture of 'curious, inspired, and unbossed,'…

Alper Ureten – VP, General Manager for Biosimilars…
Alper Ureten, Amgen VP and General Manager, sits down with PharmaBoardroom to set out his ambitions and objectives for its Biosimilars Business Unit.…

Medicines for Europe Leadership Team on Generics Industry COVID…
In conversation with PharmaBoardroom Christoph Stoller and Adrian Van den Hoven of Medicines for Europe, the association representing the European…

Bill Sibold – Executive Vice President, Sanofi Genzyme
Speaking exclusively to PharmaBoardroom, Sanofi Genzyme Executive VP Bill Sibold outlines Sanofi’s strategy for its specialty care unit, the wealth…

Reclaiming Asia’s Genomic Destiny
The completion of the Human Genome Project (HGP) in April 2003 with the publication of the first human genome sequence is probably one of the most…

Boehringer Ingelheim Creates New China External Innovation Hub
With its brand new hub in Shanghai dedicated to research, business development and venture funding, German pharma giant Boehringer Ingelheim is taking…

The Case for an Algerian FDA in the Wake of Unethical TV Ads
In the wake of a spate of television advertisements for dietary supplements claiming to offer solutions to the COVID-19 crisis, regular…

Christoph Stoller – President & Adrian van den Hoven…
In the wake of the publication of Medicines for Europe’s Lessons Learned from COVID-19 policy paper, Christoph Stoller & Adrian van den Hoven…

Launching Zolgensma® in Belgium: Lessons Learned
In late 2019 Novartis hit the headlines in Belgium after it refused to grant access to its one-off gene therapy Zolgensma® for the ultra-rare…

Algeria Pharma News Roundup July 2020
Below we present recent news from Algeria’s pharmaceutical industry, including the creation of a dedicated Ministry to boost the sector, changes to…

Can We Afford to Pay for Future Cures?
Pharmaceutical innovation is racing ahead of the US health system's ability to adjust payment models, but innovative concepts are finally emerging. We…

Jin LI – Chairman & CEO, HitGen, China
Dr Jin Li explains Chinese firm HitGen’s unique drug discovery technology platform, how its ability to screen billions of molecules has the…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here